In re Diet Drugs Products Liability Litigation
United States Court of Appeals for the Third Circuit
282 F.3d 220 (2002)
- Written by Salina Kennedy, JD
Facts
Two diet drugs, Pondimin and Redux, were found to cause heart damage and were taken off the market. As a result, thousands of lawsuits were filed by the drugs’ users in both federal and state courts nationwide. The federal lawsuits were transferred to the United States District Court for the Eastern District of Pennsylvania and consolidated. Nearly two years after the cases were transferred, the parties reached a proposed global settlement to resolve the claims of a proposed nationwide class of plaintiffs (Brown class) (plaintiffs). The Brown class included all individuals in the United States who had taken either or both drugs, as well as those individuals’ representatives and dependents. The district court conditionally certified the Brown class, preliminarily approved the settlement, and established an opt-out period. Parallel to the federal class action was a Texas state-court class action. The Texas plaintiffs’ class (Gonzalez class), a subset of the Brown class, included all individuals who had bought the drugs in Texas. One week before the end of the federal opt-out period, the Texas court granted a motion opting out all members of the Gonzalez class from the Brown settlement. The federal court entered an injunction prohibiting the Gonzalez opt-out. The Gonzalez plaintiffs appealed the injunction.
Rule of Law
Issue
Holding and Reasoning (Scirica, J.)
What to do next…
Here's why 834,000 law students have relied on our case briefs:
- Written by law professors and practitioners, not other law students. 46,500 briefs, keyed to 994 casebooks. Top-notch customer support.
- The right amount of information, includes the facts, issues, rule of law, holding and reasoning, and any concurrences and dissents.
- Access in your classes, works on your mobile and tablet. Massive library of related video lessons and high quality multiple-choice questions.
- Easy to use, uniform format for every case brief. Written in plain English, not in legalese. Our briefs summarize and simplify; they don’t just repeat the court’s language.
